Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

A Bit Of Respite For Icn's Panic


In Business This Week

A BIT OF RESPITE FOR ICN'S PANIC

The proxy fight at ICN Pharmaceuticals may be over, but the legal wrangling goes on and on. Shareholders at the drugmaker's annual meeting on Feb. 1 "overwhelmingly" supported its directors against a slate put forth by stockbroker Rafi Khan, the company says. The vote ended a 10-month offensive by Khan to unseat ICN founder Milan Panic. Now, the battle moves to a New York courtroom, where ICN is suing Khan for $75 million. It says Khan traded ICN stock using inside information. In his own suit, Khan charges Panic with illegally managing ICN while he was Prime Minister of Yugoslavia.EDITED BY KEITH H. HAMMONDS


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus